Cardiac monitoring devices are used for capturing irregular heartbeats and identify rhythm disorder and to determine the right course of treatment. These devices are used to assist in diagnosis of health conditions such as, unexplained fainting, unexplained stroke, heart palpitations, atrial fibrillation and others. On the other hand, the cardiac rhythm management devices are implantable devices that are used to treat and manage arrhythmia-related diseases. These devices are specially designed to improve the health status of patients with too slow or too fast heart rhythm.
The cardiac monitoring and cardiac rhythm management devices market is anticipated to grow with a significant rate in the coming years, owing to factors such as, increasing incidence of cardiac disorders, certain genetic errors and growing awareness programs. However, increasing technological advancements and growing aging population is anticipated to offer more growth opportunities for the players operating in the cardiac monitoring and cardiac rhythm management devices market.
The "Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global market with detailed market segmentation by product, end user, and geography. The global cardiac monitoring and cardiac rhythm management devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading cardiac monitoring and cardiac rhythm management devices market players and offers key trends and opportunities in the market.
The global cardiac monitoring and cardiac rhythm management devices market is segmented on the basis of product, and end user. Based on product, the cardiac monitoring and cardiac rhythm management devices market is bifurcated into cardiac monitoring devices and cardiac rhythm management devices. The cardiac monitoring devices segment is further segmented into ECG devices, cardiac output monitoring (COM) devices, implantable loop recorders, event monitors and mobile cardiac telemetry monitoring (MCT/MCOT). The cardiac rhythm management devices segment is also further classified as, pacemakers and defibrillators. Based on the end user, the cardiac monitoring and cardiac rhythm management devices market is segmented into hospitals, ambulatory surgical centers, home care settings and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global cardiac monitoring and cardiac rhythm management devices market based on product, and end user. It also provides market size and forecast till 2028 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cardiac monitoring and cardiac rhythm management devices market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the cardiac monitoring and cardiac rhythm management devices market in the coming years, due to growing demand for cardiac monitoring and healthcare reforms for infrastructural development in the region. However, Asia Pacific is expected to witness significant growth in the market during the forecast period, owing to rising healthcare spending and growing demand for advanced technologies in the region.
The report analyzes factors affecting cardiac monitoring and cardiac rhythm management devices market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the cardiac monitoring and cardiac rhythm management devices market in these regions.
The report also includes the profiles of key cardiac monitoring and cardiac rhythm management devices companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the cardiac monitoring and cardiac rhythm management devices market include, Abbott, Boston Scientific Corporation., Medtronic, Koninklijke Philips N.V., General Electric Company, LivaNova PLC, BIOTRONIK, Inc., Applied Cardiac Systems, Inc., BioTelemetry, Inc., Schiller and among others.
TABLE OF CONTENTS
LIST OF TABLES
LIST OF FIGURES
The List of Companies
1. Abbott
2. Boston Scientific Corporation
3. Medtronic
4. Koninklijke Philips N.V.
5. General Electric Company
6. LivaNova PLC
7. BIOTRONIK, Inc.
8. Applied Cardiac Systems, Inc.
9. BioTelemetry, Inc.
10. Schiller